Label Changes for:

Geodon (ziprasidone HCl) Capsules and Oral Suspension Geodon (ziprasidone mesylate) Injection

March 2013

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

 

March 2013

WARNINGS AND PRECAUTIONS

Hyperprolactinemia
  • ...Long-standing hyperprolactinemia when associated with hypogonadism may lead to decreased bone density.
Hide
(web3)